Akèy › Adenokasinom Ezofajyen › Missouri › St. Louis
Etid klinik pou Adenokasinom Ezofajyen nan St. Louis, MO
9 etid pou Adenokasinom Ezofajyen ap chèche patisipan nan sit nan ak bò kote St. Louis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Ap rekriteFaz 2/3
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- ak 3 plis
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Ap rekriteFaz 3
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- ak 4 plis
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
Ap rekriteFaz 2
- Washington University School of Medicine, St Louis
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Ap rekrite
- Washington University in St. Louis, St Louis
A Study of KK2269 in Adult Participants With Solid Tumors
Ap rekriteFaz 1
- Washington University, St Louis
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Ap rekriteFaz 3
- Research Site, St Louis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Ap rekriteFaz 1
- Normunity Investigational Site, St Louis
Obeticholic Acid for Prevention in Barrett's Esophagus
Ap rekriteFaz 2
- Washington University School of Medicine, St Louis
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- Research Site, St Louis
Etid Adenokasinom Ezofajyen nan lòt vil
- New York City, NY18 etid
- Boston, MA13 etid
- Houston, TX12 etid
- Nashville, TN11 etid
- Arlington, VA11 etid
- Durham, NC10 etid
- Jacksonville, FL9 etid
- Baldwin Park, CA9 etid
- Rochester, MN9 etid
- Queens, NY9 etid
- Los Angeles, CA9 etid
- Dallas, TX8 etid
Lòt etid nan St. Louis
- Kansè Poumon ki pa ti selil73 etid
- Kansè nan tete64 etid
- Kansè Metastatik54 etid
- Kansè kolorektal50 etid
- Kansè (tout kalite)46 etid
- Kansè pwostat46 etid
- Kansè poumon39 etid
- Kansè ovè38 etid
- Kansè pankreyas33 etid
- Kansè Endomèt29 etid
- Karsinòm selil skuamèz tèt ak kou28 etid
- Ensifizyans kadyak26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.